EVOLUTION OF THE UTILIZATION OF THE AIFA 5% FUND FOR ORPHAN DRUGS AND RARE DISEASES

被引：0
|
作者：
Tartarelli, F. [1 ]
Viola, V. [2 ]
Lidonnici, D. [3 ]
Marcellusi, A. [4 ]
机构：
[1] Sapienza Univ Roma, Rome, Italy
[2] Pharmavalue, Rome, Italy
[3] More Access Srl SB, Legnano, MI, Italy
[4] Univ Roma Tor Vergata, Fac Econ, Dept Econ & Finance, Econ Evaluat & HTA EEHTA CEIS, Rome, Italy
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HPR29
引用
收藏
页码：S259 / S259
页数：1
相关论文
共 50 条
  • [31] Orphan Drugs for Rare Diseases: Grounds for Special Status
    Picavet, Eline
    Dooms, Marc
    Cassiman, David
    Simoens, Steven
    DRUG DEVELOPMENT RESEARCH, 2012, 73 (03) : 115 - 119
  • [32] Rare diseases and orphan drugs in Eastern European Countries
    Stefanov, Rumen
    Taruscio, Domenica
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2009, 6 (04): : 289 - 293
  • [33] Rare diseases, orphan drugs and their regulation: questions and misconceptions
    Erik Tambuyzer
    Nature Reviews Drug Discovery, 2010, 9 : 921 - 929
  • [34] Orphan drugs and orphan diseases
    Campos-Castelló, J
    REVISTA DE NEUROLOGIA, 2001, 33 (03) : 216 - 220
  • [35] Drugs for Rare Diseases: Influence of Orphan Designation Status on Price
    Picavet, Eline
    Dooms, Marc
    Cassiman, David
    Simoens, Steven
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2011, 9 (04) : 275 - 279
  • [36] Current progress in the management of rare diseases and orphan drugs in China
    Gong, Shiwei
    Jin, Si
    INTRACTABLE & RARE DISEASES RESEARCH, 2012, 1 (02) : 45 - 52
  • [37] Orphan drugs. New opportunities for the treatment of rare diseases
    Beck, M.
    INTERNIST, 2016, 57 (11): : 1132 - 1137
  • [38] Therapeutic potential of orphan drugs for the rare skeletal muscle diseases
    Swiderski, Kristy
    Lynch, Gordon S.
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (12): : 1397 - 1426
  • [39] Drugs and orphan diseases
    Blin, Olivier
    Micallef, Joelle
    THERAPIE, 2020, 75 (02): : 131 - 132
  • [40] FINANCING OF MEDICINES FOR TREATMENT OF RARE DISEASES OF THE NERVOUS SYSTEM. ORPHAN DRUGS IN RARE NEUROLOGICAL DISEASES
    Szegedi, Marta
    Kosztolanyi, Gyoergy
    Boncz, Imre
    Molnar, Maria Judit
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2016, 69 (1-2): : 37 - 45
12345